WO2007127813A3 - Modulation of signal transduction by site specific ultrasound agent delivery of transmembrane acting compounds - Google Patents

Modulation of signal transduction by site specific ultrasound agent delivery of transmembrane acting compounds Download PDF

Info

Publication number
WO2007127813A3
WO2007127813A3 PCT/US2007/067438 US2007067438W WO2007127813A3 WO 2007127813 A3 WO2007127813 A3 WO 2007127813A3 US 2007067438 W US2007067438 W US 2007067438W WO 2007127813 A3 WO2007127813 A3 WO 2007127813A3
Authority
WO
WIPO (PCT)
Prior art keywords
signal transduction
transmembrane
site specific
modulation
agent delivery
Prior art date
Application number
PCT/US2007/067438
Other languages
French (fr)
Other versions
WO2007127813A2 (en
Inventor
Margaret Wheatley
Kelleny Oum
Original Assignee
Univ Drexel
Margaret Wheatley
Kelleny Oum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Drexel, Margaret Wheatley, Kelleny Oum filed Critical Univ Drexel
Publication of WO2007127813A2 publication Critical patent/WO2007127813A2/en
Publication of WO2007127813A3 publication Critical patent/WO2007127813A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins

Abstract

This invention relates to a site specific transmembrane acting ultrasound imaging agent suitable for inducing and modulating a signal transduction cascade in a targeted cells and to methods of inducing and modulating signal transduction in targeted cells together with imaging the site of the attachment of the ultrasound contrast agent.
PCT/US2007/067438 2006-04-25 2007-04-25 Modulation of signal transduction by site specific ultrasound agent delivery of transmembrane acting compounds WO2007127813A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79460306P 2006-04-25 2006-04-25
US60/794,603 2006-04-25

Publications (2)

Publication Number Publication Date
WO2007127813A2 WO2007127813A2 (en) 2007-11-08
WO2007127813A3 true WO2007127813A3 (en) 2008-07-31

Family

ID=38656362

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/067438 WO2007127813A2 (en) 2006-04-25 2007-04-25 Modulation of signal transduction by site specific ultrasound agent delivery of transmembrane acting compounds

Country Status (1)

Country Link
WO (1) WO2007127813A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220072130A1 (en) * 2018-12-23 2022-03-10 B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University Stable microspheres, method off abrication and use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US7238786B2 (en) * 2002-06-14 2007-07-03 Immunomedics, Inc. Monoclonal antibody cPAM4

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7083572B2 (en) * 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US7238786B2 (en) * 2002-06-14 2007-07-03 Immunomedics, Inc. Monoclonal antibody cPAM4

Also Published As

Publication number Publication date
WO2007127813A2 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
WO2008100805A3 (en) Anti-robo4 antibodies and uses therefor
EP2029034B8 (en) Ultrasonic surgical instrument
EP2315634B8 (en) Medical ultrasound transducer assembly, and medical ultrasound handpiece and system having such assembly
EP1741390B8 (en) Ultrasonic diagnosis device
EP2347500A4 (en) System and method of driving ultrasonic transducers
EP1986554B8 (en) Tissue tack
EP2097937A4 (en) Electroactive polymer transducers biased for optimal output
EP2227155B8 (en) Ultrasonic surgical blades
WO2007077561A3 (en) Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents
EP2351994A4 (en) Ultrasonic flowmeter
EP2086826A4 (en) Self-propelled vehicle propelled by an elliptical drive train
EP2138100B8 (en) Portable ultrasonic diagnostic apparatus
ZA201009167B (en) Ultrasonic transducer system
HK1136241A1 (en) Ultrasound liquid atomiser
EP1962552A4 (en) Ultrasonic transducer
EP2064994A4 (en) Resonance ultrasonic transducer
WO2008002449A3 (en) Glycomimetic inhibitors of siglec-8
EP2076061A4 (en) Ultrasonic transducer
EP1993588A4 (en) Tissue adhesives and sealants and methods for their use
EP1916946A4 (en) Driver configuration for an ultrasonic flow meter
WO2009020683A3 (en) Quinazoline compounds
WO2009146099A3 (en) Contrast agents, methods for preparing contrast agents, and methods of imaging
WO2008057396A3 (en) Canine lyme disease vaccine
EP3031439B8 (en) System for generating ultrasonic waves
EP1971281A4 (en) Ultrasonic medical instrument

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07761297

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07761297

Country of ref document: EP

Kind code of ref document: A2